Article metrics

Download PDFPDF

770 Safety, efficacy, and pharmacokinetic results from a phase I first-in-human study of ABBV-151 with or without anti-PD1 mAb (budigalimab) in patients with locally advanced or metastatic solid tumors
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022300014
Dec 2022117015
Jan 2023142012
Feb 2023224027
Mar 2023246018
Apr 2023156015
May 2023162018
Jun 2023156023
Jul 2023142017
Aug 202389022
Sep 202390028
Oct 2023126019
Nov 2023178039
Dec 2023170019
Jan 2024106016
Feb 2024250020
Mar 2024166019
Total28200341